
Teriparatide acetate
CAS No. 99294-94-7
Teriparatide acetate( Parathar acetate | hPTH 1-34 (acetate salt) | Forteo )
Catalog No. M25029 CAS No. 99294-94-7
Teriparatide (Human parathyroid hormone-(1-34)) is a PHT agonist, with an IC50 of 2 nM in HEK293 cells.Teriparatide is a recombinant form of parathyroid hormone.?
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 126 | In Stock |
![]() ![]() |
10MG | 176 | In Stock |
![]() ![]() |
25MG | 266 | In Stock |
![]() ![]() |
50MG | 372 | In Stock |
![]() ![]() |
100MG | 464 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameTeriparatide acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionTeriparatide (Human parathyroid hormone-(1-34)) is a PHT agonist, with an IC50 of 2 nM in HEK293 cells.Teriparatide is a recombinant form of parathyroid hormone.?
-
DescriptionTeriparatide (Human parathyroid hormone-(1-34)) is a PHT agonist, with an IC50 of 2 nM in HEK293 cells.Teriparatide is a recombinant form of parathyroid hormone.?It is an effective anabolic (i.e., bone growing) agent used to treat some forms of osteoporosis.?Intermittent use of Teriparatide activates osteoblasts more than osteoclasts, which leads to an overall increase in bone.(In Vivo):Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) (20 μg/kg, i.h.; daily, for 4 weeks; female New Zealand white rabbits) increases the cortical thickness and porosity.
-
In Vitro——
-
In VivoTeriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) (20 μg/kg, i.h.; daily, for 4 weeks; female New Zealand white rabbits) increases the cortical thickness and porosity. Animal Model:Female New Zealand white rabbits Dosage:20 μg/kg Administration:Subcutaneous injection; daily, for 4 weeksResult:Increased the pore ratio, number, and density as well as the cortical area, thickness, and bone mineral content (BMC), without significant influencing the volumetric bone mineral density (BMD).
-
SynonymsParathar acetate | hPTH 1-34 (acetate salt) | Forteo
-
PathwayOthers
-
TargetOther Targets
-
RecptorPHT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number99294-94-7
-
Formula Weight4177.83
-
Molecular FormulaC183H295N55O53S2
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble; Water:Insoluble
-
SMILESCC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N.CC(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lindsay R, Krege JH, Marin F, Jin L, Stepan JJ. Teriparatide for osteoporosis: importance of the full course. Osteoporos Int. 2016 Feb 22. [Epub ahead of print] Review. PubMed PMID: 26902094.
molnova catalog



related products
-
DSR-6434
DSR-6434 has a strong antitumor effect. DSR-6434 is a potent and selective Toll-like receptor 7 (TLR7) agonist, with EC50s of 7.2 nM and 4.6 nM for human and mice TLR7, respectively.
-
DL-Homocysteic acid
DL-Homocysteic acid is a useful organic compound for research related to life sciences.
-
Enprofylline
Enprofylline, a bronchodilator, acts primarily as a competitive nonselective phosphodiesterase inhibitor.